| Similar Articles |
|---|
 |
Reason
March 2007
Radley Balko |
Cold Comfort Given all the abuse the drug companies were taking because of meth cooks' illegal use of their products, you could almost forgive Pfizer for putting a useless product on the shelves.   |
Reason
January 2005
Jacob Sullum |
Speed Tracers Under plans being considered in Indiana and Oregon to help curtail methamphetamine labs, consumers who want to purchase Sudafed or other remedies that contain pseudoephedrine would have to wait in line at the pharmacy counter, show ID, and sign a registry. |
Reason
July 2008
Katherine Mangu-Ward |
Data: Meth Math The nation's largest drug testing company reports that the share of job applicants and employees testing positive for methamphetamine fell 22 percent between 2006 and 2007. |
Health
March 2006
Eric Steinmehl |
If Echinacea Doesn't Help With pseudoephedrine off the shelves you can reach, how do the new cold medicines stack up? |
Chemistry World
October 12, 2006
Richard Van Noorden |
Methamphetamine Crooks Down on the Farm Researchers have discovered a way to curb illegal methamphetamine production across agricultural states in the US by adding a chemical to farmers' fertilizer, which is often stolen to help cook up drug. |
The Motley Fool
February 2, 2005
Alyce Lomax |
CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny. |
The Motley Fool
October 31, 2008
Timothy M. Otte |
CVS Caremark Takes Care of Its Investors The drugstore giant continues to scoop up market share. |
The Motley Fool
October 6, 2008
Brian Orelli |
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated. |
The Motley Fool
May 5, 2004
Mike Cianciolo |
CVS Prescribes Growth The soon-to-be leader of the drugstore market had a spectacular first quarter as a result of improved sales and margins, and CVS doesn't appear to be showing any signs of slowing down either, as the company continues to expand its business in both traditional and creative ways. |
The Motley Fool
June 10, 2004
Alyce Lomax |
Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition. |
The Motley Fool
May 4, 2011
Jason Knapp |
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. |
The Motley Fool
January 3, 2005
Nathan Slaughter |
Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground. |
The Motley Fool
April 9, 2007
Mike Cianciolo |
CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note. |
The Motley Fool
March 28, 2005
Alyce Lomax |
A Cool Quarter for Walgreen Are second-quarter earnings putting a damper on Walgreen? |
The Motley Fool
March 9, 2005
Steven Mallas |
CVS Comps Feast on Flu CVS enjoys a nice jump in same-store sales for the month of February -- thanks, in part, to colds and the flu. |
BusinessWeek
September 19, 2005
Gene G. Marcial |
CVS' Ever-Expanding Aisles According to analysts, the aging population and improving pipeline of new drugs will help the retail pharmacy achieve its goal of 15% overall long-term earnings growth. Investors, take note. |
The Motley Fool
August 1, 2007
Ryan Fuhrmann |
Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one. |
The Motley Fool
January 8, 2007
Matthew Crews |
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. |
National Real Estate Investor
February 1, 2006
Christine Perez |
Drugstore Addiction Drugstores are offering a healthy alternative for buyers of commercial real estate. Even as chains add new locations at a record pace, they're quietly overtaking grocery-anchored centers as a preferred product type among retail investors. |
The Motley Fool
June 10, 2010
Claire Stephanic |
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. |
Chemistry World
July 31, 2015
Rebecca Trager |
US government science institute's one time police chief linked to campus meth lab A methamphetamine lab was discovery at the NIST's Maryland facility, prompting questions over security at the institute. |
The Motley Fool
January 13, 2004
Alyce Lomax |
CVS Fever Drug stores benefit from the flu bug, but for how much longer? |
The Motley Fool
May 8, 2007
Ryan Fuhrmann |
CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results. |
The Motley Fool
November 9, 2005
Steven Mallas |
CVS Needs Rx for Cash The drugstore chain has the prescription for earnings growth, but investors need to keep an eye on free cash flow. |
The Motley Fool
February 2, 2007
Ryan Fuhrmann |
Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share. |
The Motley Fool
June 14, 2010
Rich Smith |
Is CVS' $2 Billion Buyback Good Medicine? Don't assume just because CVS is buying its stock, that this is a good idea. |
The Motley Fool
June 2, 2011
Dee Gill |
CVS's Improved Performance Begins to Drown Out the Dump-Caremark Chants Is the prognosis for CVS looking up? |
The Motley Fool
June 2, 2004
Alyce Lomax |
Walgreen's Mellow May Will the drugstore chain get a taste of its own medicine? |
The Motley Fool
July 20, 2005
Warren Gump |
Will Perrigo's Prescription Work? Perrigo, the nation's largest maker of private-label over-the-counter (OTC) drugs, is setting new 52-week lows. Nonetheless, if management delivers as it has over the past few years, the longer-term outlook looks promising. |
The Motley Fool
March 24, 2004
Dave Marino-Nachison |
Eking Out an Eckerd Deal Investors are still waiting for a new leader to be crowned in the U.S. drugstore business. |
The Motley Fool
March 26, 2010
Cathy Applefeld Olson |
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup. |
The Motley Fool
January 23, 2006
Tim Beyers |
SUPERVALU Goes Shopping The retailer snaps up Albertsons, but CVS gets the spoils. Investors, take note. |
TIME Asia
May 30, 2011
Andrew Marshall |
Drugged Out Northern Laos was once notorious for opium, and its derivative, heroin. Together with Thailand and Burma, this mountainous region makes up the Golden Triangle, which once provided at least half of the world's opium supply. |
BusinessWeek
April 9, 2007
Gene G. Marcial |
Hail To CVS/Caremark Deal or no deal, CVS was already a fave on Wall Street. And now that it has acquired Caremark Rx, No.2 in pharmacy-benefits management, Goldman Sachs, UBS, and Matrix USA are even more bullish. |
The Motley Fool
October 5, 2007
Timothy M. Otte |
CVS: Consistently Very Solid The drugstore giant scores a consistent sales increase in September, as it begins to capitalize on synergies from its CareMark acquisition. |
The Motley Fool
January 13, 2009
Dayana Yochim |
Fiscal Fitness '09: 6 Ways to Score Cheap(er) Drugs Save more than $200 on prescriptions. |
The Motley Fool
November 2, 2006
Ryan Fuhrmann |
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. |
The Motley Fool
September 14, 2006
Ryan Fuhrmann |
Playing Defense With the Drugstore Industry Retail pharmacy August sales trends help investors discern the leader in this appealing sector. |
The Motley Fool
November 8, 2006
Michael P. Cecil |
CVS/Caremark: A Brobdingnagian Drug Seller The merger of CVS and Caremark says a lot about pharmaceutical retailers and pharmacy benefit mangers trying to deal with a rapidly changing paradigm. |
